title: [Abuse-related adverse drug reactions and abuse deterrent formulations].
authors.affiliation: Grupo de Investigación Clínica en Farmacología Humana y Neurociencias, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Parc de Salut Mar, Barcelona, España; Departamento de Farmacología, de Terapéutica y de Toxicología, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Barcelona, España; Departamento de Psiquiatría, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Barcelona, España.
authors.forename: Esther
authors.initials: E
authors.lastname: Papaseit
authors.forename: Clara
authors.initials: C
authors.lastname: Pérez-Mañá
authors.forename: Marta
authors.initials: M
authors.lastname: Torrens
authors.forename: Magí
authors.initials: M
authors.lastname: Farré
mesh_terms: D002626:Chemistry, Pharmaceutical / Q000331:legislation & jurisprudence / Q000379:methods; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004339:Drug Compounding; D004347:Drug Interactions; D004348:Drug Labeling; D062787:Drug Overdose / Q000517:prevention & control; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D005062:European Union; D006184:Habits; D013287:Illicit Drugs / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D009294:Narcotics / Q000008:administration & dosage / Q000009:adverse effects; D010342:Patient Acceptance of Health Care; D058573:Performance-Enhancing Substances / Q000009:adverse effects; D011355:Prodrugs / Q000008:administration & dosage / Q000493:pharmacokinetics; D011358:Product Surveillance, Postmarketing; D011619:Psychotropic Drugs / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000209:etiology / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D003692:Delayed-Action Preparations; D004338:Drug Combinations; D013287:Illicit Drugs; D009292:Narcotic Antagonists; D009294:Narcotics; D058573:Performance-Enhancing Substances; D011355:Prodrugs; D011619:Psychotropic Drugs